Drugs / gpASIT+TM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02156791 | Aug → Dec 2013 | seasonal allergic rhinitis | BioTech Tools S.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gpASIT+TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02156791 ↗ |
| Modality | Protein / enzyme biologic | “gpASIT+TM product is based on highly purified allergen fragments obtained from grass pollen.” NCT02156791 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT02156791 ↗ |